Dual-Use Research: India’s Institutional Governance Pilots

Why in News?

WHO reported on 29 September 2026 that Indian research institutions and laboratory networks were piloting its framework, training and BRIET to strengthen dual-use research governance, with piloting expected to conclude by end-2026.

• BRIET means Biorisk Implementation and Evaluation Tool; WHO launched it on 28 August, before the September implementation update.
• India’s reported activity consists of institutional-level pilots, not a newly enacted national law or a completed nationwide rollout.
• The pilots aim to strengthen risk-based decision-making and document lessons for future scale-up; evaluated Indian outcomes have not been established by the cited account.

• Beneficial research can generate knowledge or tools that others misuse; oversight must consider possible consequences alongside the original scientific purpose.
• Institutional responsibility connects researchers, leadership and other stakeholders so that identified governance gaps lead to assigned corrective actions.

UPSC Relevance

Prelims Relevance

• Dual-use research and dual-use research of concern
• BRIET as a voluntary structured self-assessment tool
• WHO as the tool’s developer
• Institutional pilots versus binding national regulation
• Biorisk encompassing accidents, inadvertent actions and deliberate misuse

Mains Relevance

GS Paper 3

• Responsible life-sciences innovation
• Institutional governance of emerging scientific risks

GS Paper 2

• Global guidance and domestic implementation capacity

Essay

• Scientific freedom and responsibility for foreseeable consequences

Background and Context

Why Beneficial Research Needs Oversight

Dual-use governance asks how useful scientific work could also cause harm, and what responsibilities follow from that possibility.

• Dual-use research begins with peaceful or beneficial purposes but may produce knowledge, information or technologies that could be intentionally misused. The concern attaches to possible application, not an automatic allegation against the researcher.
• Dual-use research of concern is a subset that could be easily misapplied with little or no modification. This narrower category helps distinguish particularly sensitive work from the broader possibility that scientific knowledge has multiple uses.
• Biorisk is broader than deliberate misuse: WHO includes accidents and inadvertent actions that could adversely affect people, animals, plants, agriculture or the environment. Governance must recognise these different sources of potential harm.
• Responsible oversight connects scientific benefit with foreseeable risk and institutional capacity. The practical governance question is who examines a concern, who decides on a proportionate response, and who checks whether that response remains appropriate.
• Physical laboratory safeguards alone do not answer every governance question. Responsible research also requires attention to decision-making, stakeholder roles and the possible use of resulting knowledge, even when laboratory operations follow established safety arrangements.

How BRIET Turns Assessment Into Action

The tool helps users organise an assessment and plan improvements; its recommendations still require people and institutions to act on them.

• WHO’s launch account describes BRIET as a voluntary, structured self-assessment and capacity-strengthening tool. Its role is to support governance improvement, rather than issue a compulsory legal licence for research.
• Stakeholder mapping identifies relevant actors and their responsibilities. Bringing these roles into one assessment can reveal where coordination is weak or a governance task lacks a clear owner, rather than assuming somebody else handles it.
• Gap assessment compares existing strengths and weaknesses across governance capacities. Users can identify priorities and receive tailored recommendations, but the usefulness of the resulting picture depends on the information and judgement entered into the assessment.
• Action planning converts identified gaps into improvements that fit local conditions. A sound institutional response should assign responsibility and review progress; simply recording a weakness does not demonstrate that the underlying problem has been resolved.
• Repeated assessment can help track change over time and refine priorities. It should support evidence-based decisions, while avoiding the inference that a completed questionnaire independently certifies that all relevant risks are under control.

What the Indian Pilots Establish

The verified development is ongoing institutional implementation; its scale, legal status and results should be stated with care.

• The September WHO update identifies research institutions and laboratory networks in India applying the framework, WHO Academy course and BRIET to strengthen dual-use governance and document lessons for possible future scale-up.
• Expected completion by the end of the year is a forward-looking pilot timeline. It is not evidence that the work has finished, that all institutions participate, or that an independently evaluated improvement has already occurred.
• Institutional implementation differs from binding national regulation. The cited account does not announce a new Indian legal requirement, name a nationwide licensing authority or establish that use of the WHO tool is compulsory.
• Cross-sector ownership matters because researchers cannot resolve every governance issue alone. Institutional leaders, funders, publishers and relevant authorities can influence how responsibilities are understood and how research concerns receive appropriate consideration.
• Scale-up should depend on documented lessons about feasibility, coordination and continuing capacity. Adapting a global framework to local institutions requires more than copying a checklist, especially when expertise and organisational responsibilities vary across settings.

Way Forward

Make Responsibilities Reviewable

• Assign an institutional owner to each priority governance gap and record what improvement would count as progress.
• Build multidisciplinary review capacity so scientific benefits and foreseeable risks receive informed, proportionate consideration.
• Publish appropriate pilot lessons on governance and coordination while protecting sensitive information; distinguish expected benefits from demonstrated results.

Conclusion

• Dual-use governance makes responsibility part of scientific practice: useful research needs institutions capable of recognising concerns, coordinating decisions and following through on proportionate improvements without treating all innovation as suspect.
• India’s ongoing pilots offer a setting to learn how WHO guidance works institutionally. The next evidence to seek is documented implementation experience, rather than assuming that a voluntary tool already constitutes national regulation or proven success.

UPSC Practice Questions

Prelims MCQ 1

With reference to BRIET, consider the following statements:

1. It is a voluntary structured self-assessment tool developed by WHO.
2. Its use automatically establishes compliance with a newly enacted Indian national law.
3. It can help institutions identify governance gaps and prioritise actions.

How many of the above statements are correct?

(a) Only one (b) Only two (c) All three (d) None

Answer: (b) Only two

Explanation:

Statements 1 and 3 are correct. BRIET supports assessment and capacity strengthening. The cited WHO account does not establish a new Indian law or automatic legal compliance.

Prelims MCQ 2

Which statement best describes dual-use research?

(a) Research necessarily undertaken with an intention to cause harm (b) Research conducted only by military institutions (c) Beneficial research whose outputs could also be intentionally misused (d) Research that must always involve two countries

Answer: (c) Beneficial research whose outputs could also be intentionally misused

Explanation:

Dual-use research can have peaceful and beneficial purposes while generating knowledge, information or technologies that could be intentionally misused. It does not imply malicious intent by the original researcher.

UPSC Mains Questions

1. Why does responsible life-sciences research require institutional governance beyond physical laboratory safety? Discuss with reference to dual-use research.
2. Assess the opportunities and limitations of voluntary self-assessment tools in strengthening research governance. How should lessons from institutional pilots inform wider adoption?

Sources: WHO and WHO BRIET launch account.

Frequently Asked Questions